ArticleJournal of pain research2025
Electroacupuncture for the Subacute Stage of Lumbar Disc Herniation: A Randomized Controlled Trial Protocol with EEG.
Article in Journal of pain research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aims to elucidate the central mechanisms of electroacupuncture (EA) for subacute lumbar disc herniation (LDH) using electroencephalography (EEG). To our knowledge, this is the first study to apply EEG to characterize the neurophysiological correlates of EA treatment in this specific clinical condition. Patients and Methods: In this randomized controlled trial, a total of 66 patients with subacute lumbar disc herniation (LDH) will be enrolled from the Departments of Acupuncture and Orthopedics. Participants will be randomly allocated at a 1:1 ratio to either an EA group or a sham EA group, resulting in 33 participants per group. The primary outcomes are the clinical efficacy rate and the Japanese Orthopaedic Association (JOA) score. Secondary outcomes include the Oswestry Disability Index (ODI) and the Visual Analogue Scale (VAS) for pain. Clinical outcomes will be assessed at baseline, two weeks, four weeks (end of treatment), and at a three-month follow-up. The neuroimaging outcome is EEG. EEG data will be collected at baseline and at the four-week endpoint, with analyses focusing on core parameters such as power spectral density (PSD) analysis, time-frequency analysis, and microstate analysis. Conclusion: This study will verify the clinical efficacy of electroacupuncture in treating subacute LDH and explore its core central mechanisms using EEG technology. We anticipate that the expected improvements in clinical outcomes (eg, JOA, ODI, and VAS scores) will significantly correlate with the normalization of aberrant neural oscillations-specifically, a reduction in theta power and restoration of alpha activity. Such findings would provide direct neuroimaging evidence for EA's central neuromodulatory role, offering a mechanistic basis for its broader clinical application in the treatment of LDH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.